Crixus BH3 Acquisition Statistics
Share Statistics
Crixus BH3 Acquisition has 6.95M shares outstanding. The number of shares has increased by -37.15% in one year.
| Shares Outstanding | 6.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 361.30K |
| Failed to Deliver (FTD) Shares | 180 |
| FTD / Avg. Volume | 25.1% |
Short Selling Information
The latest short interest is 1.81K, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 1.81K |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.5% |
| Short Ratio (days to cover) | 1.19 |
Valuation Ratios
The PE ratio is 13.44 and the forward PE ratio is null.
| PE Ratio | 13.44 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 4.71 |
| P/FCF Ratio | -54.42 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Crixus BH3 Acquisition.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.27, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.27 |
| Quick Ratio | 0.27 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 1.52 |
| Cash Flow / Debt | -5.62 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.35% and return on capital (ROIC) is -6.97%.
| Return on Equity (ROE) | 0.35% |
| Return on Assets (ROA) | 0.31% |
| Return on Capital (ROIC) | -6.97% |
| Revenue Per Employee | 0 |
| Profits Per Employee | 2.63M |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 510.29K |
| Effective Tax Rate | 0.06 |
Stock Price Statistics
The stock price has increased by -1.92% in the last 52 weeks. The beta is 0, so Crixus BH3 Acquisition's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -1.92% |
| 50-Day Moving Average | 10.43 |
| 200-Day Moving Average | 10.57 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 717 |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.69M |
| Operating Income | -1.69M |
| Net Income | 7.88M |
| EBITDA | -1.69M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 631.34K in cash and 346.35K in debt, giving a net cash position of 284.98K.
| Cash & Cash Equivalents | 631.34K |
| Total Debt | 346.35K |
| Net Cash | 284.98K |
| Retained Earnings | -1.55M |
| Total Assets | 13.57M |
| Working Capital | -6.98M |
Cash Flow
In the last 12 months, operating cash flow was -1.94M and capital expenditures 0, giving a free cash flow of -1.94M.
| Operating Cash Flow | -1.94M |
| Capital Expenditures | 0 |
| Free Cash Flow | -1.94M |
| FCF Per Share | -0.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BHAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 7.62% |
| FCF Yield | -2.73% |
Analyst Forecast
Currently there are no analyst rating for BHAC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.57 |
| Piotroski F-Score | 4 |